TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GrzesMed AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
124
|
121 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
8
|
0 | |
| EBITDA |
8
|
1 | |
| Total assets |
39
|
55 | |
| Current assets |
39
|
55 | |
| Current liabilities |
17
|
14 | |
| Equity capital |
22
|
41 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
56.4%
|
74.5% | |
| Turnover per employee |
124
|
121 | |
| Profit as a percentage of turnover |
6.5%
|
0% | |
| Return on assets (ROA) |
20.5%
|
0% | |
| Current ratio |
229.4%
|
392.9% | |
| Return on equity (ROE) |
36.4%
|
0% | |
| Change turnover |
7
|
-66 | |
| Change turnover % |
-10%
|
6%
|
-35% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.